Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.30
Delayed Data
As of 11:29am ET
 +0.0101 / +0.78%
Today’s Change
1.14
Today|||52-Week Range
2.00
+5.69%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.29
Today’s open1.30
Day’s range1.30 - 1.37
Volume18,708
Average volume (3 months)65,200
Market cap$49.8M
Dividend yield--
Data as of 11:29am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...-0.05-2.33%
EBIOEleven Biotherapeuti...-0.03-1.46%
AVEOAveo Pharmaceuticals...-0.01-1.48%
GLMDGalmed Pharmaceutica...-0.11-2.71%
Data as of 11:51am ET, 01/20/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts


Search for Jobs